References
- Ammar H. O., Salama H. A., Ghorab M., Mahmoud A. A. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems. Int. J. Pharm 2006; 309(1–2)129–138
- Ashwinkumar C. J., Moji C. A. Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether β-cyclodextrins and danazol-SBE inclusion complexes. Int. J. Pharm 2001; 212(2)177–186
- Astakhova A. V., Demina N. B. Modern drug technologies: synthesis, characterization, and use of inclusion complexes between drugs and cyclodextrins (a review). Pharm. Chem. J 2004; 38(2)105–108
- Bibby D. C., Davies N. M., Tucker I. G. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int. J. Pharm 2000; 197(1–2)1–11
- Brewster M. E. Parenteral safety and applications of 2-hydroxypropyl β-cyclodextrin. New Trends in Cyclodextrins and Derivatives, D. Duchêne. Informa UK Ltd, Paris 1991; 27–54
- Cabral Marques H. M., Hadgraft J., Kellaway I. W. Studies of cyclodextrin inclusion complexes. I. The salbutamol-cyclodextrin complex as studied by phase solubility and DSC. Int. J. Pharm 1990; 63(3)259–266
- Cavalli R., Peira E., Caputo O., Gasco M. R. Solid lipid nanoparticles as carriers of hydrocortisone and progesterone complexes with β-cyclodextrins. Int. J. Pharm 1999; 182(1)59–69
- Cerchiara T., Luppi B., Bigucci F., Zecchi V. Effect of chitosan on progesterone release from hydroxypropyl-β-cyclodextrin complexes. Int. J. Pharm 2003; 258(1–2)209–215
- Challa R., Ahuja A., Ali J., Khar R. K. Cyclodextrins in drug delivery: an updated review. AAPS Pharm. Sci. Tech 2005; 6(2)E329–357
- Coleman A. W., Nicholis I., Keller N., Dalbiez J. Aggregation of cyclodextrins: an explanation of the abnormal solubility of β-cyclodextrin. J. Incl. Phen. Mol. Recogn. Chem 1992; 13: 139–143
- Craig D. Q. M. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm 2002; 231(2)131–144
- Cydex (2003), Frequently Asked Questionshttp://www.cydexinc.com
- Djedaïni F., Perly B. NMR investigation of the stoichiometries of β-cyclodextrin steroid inclusion complexes. J. Pharm. Sci 1991; 80(12)1157–1161
- Duclos, R. (1989). Amélioration de la biodisponibilité de la progestérone naturelle par utilisation de dispersions solides dans le polyoxyéthylène glycol 6000. Thèse de Doctorat d'Etat ès Sciences Pharmaceutiques. Université de Rouen
- Forgo P., Göndös G. A study of β-cyclodextrin inclusion complexes with progesterone and hydrocortisone using rotating frame overhauser spectroscopy. Monatsh. Chem 2002; 133(1)101–106
- González-Gaitano G., Rodríguez P., Isasi J. R., Fuentes M., Tardajos G., Sanchez M. The aggregation of cyclodextrins as studied by correlation spectroscopy. J. Incl. Phen. and Macrocyclic Chem 2002; 44(1–4)101–105
- Harris J. Laboratory synthesis of polyethylene glycol derivatives. J. Macromol. Sci. Rev. Macromol. Chem. Phys., C25 1985; 32: 5–373
- Higuchi T., Connors K. A. Phase solubility techniques. Adv. Anal. Chem. Instrum 1965; 4(2)117–212
- JECFA. Toxicological evaluation of certain food additives: polyethylene glycols. WHO Food Additives. Series, no. 14, 1980
- Le Questel J.-Y., Boquet G., Berthelot M., Laurence C. Hydrogen bonding of progesterone: a combined theoretical, spectroscopic, thermodynamic, and crystallographic database study. J. Phys. Chem. B 2000; 104(49)11816–11823
- Lin S.-Z., Skiba M., Wouessidjewe D., Agnus B., Duchêne D. Inclusion complexes of progesterone and its analogue X with cyclodextrins. Minutes of the Sixth International Symposium on Cyclodextrins. Editions de Santé 1992; 46: 0–465
- Lin S.-Z., Kohyama N., Tsuruta H. Characterization of steroid/cyclodextrin inclusion compounds by X-ray powder diffractometry and thermal analysis. Industrial Health 1996; 34: 143–148
- Liu F. Y., Kildsig D. O., Mitra A. K. Beta-cyclodextrin/Steroid complexation: effect of steroid structure on association equilibria. Pharm. Res 1990; 7(8)869–873
- Loftsson T., Brewster M. Pharmaceutical applications of cyclodextrins. I: Drug solubilization and stabilization. J. Pharm. Sci 1996; 85(10)1017–1025
- Luppi B., Cerchiara T., Bigucci F., Caponio D., Zecchi V. Bovine serum albumine nanospheres carrying progesterone inclusions complexes. Drug Deliv 2005; 12(5)281–287
- McCormack B., Gregoriadis G. Drugs-in cyclodextrins-in liposomes: a novel concept in drug delivery. Int. J. Pharm 1994; 112(3)249–258
- Nandi I., Bateson M., Bari M., Joshi H. N. Synergestic effect of PEG-400 and cyclodextrin to enhance solubility of progesterone. AAPS Pharm. Sci. Tech 2003; 4(1)1–5
- Pitha J., Pitha J. Amorphous water-soluble derivatives of cyclodextrins: non-toxic dissolution enhancing excipients. J. Pharm. Sci 1985; 74(9)987–990
- Pitha J., Harman S. M., Michel M. E. Hydrophilic cyclodextrin derivatives enable effective oral administration of steroidal hormones. J. Pharm. Sci 1986; 75(2)165–167
- Preiss A., Mehnert W., Fromming K. H. Complexation of hydrocortisone with β cyclodextrin and hydroxypropyl-β-cyclodextrin. Arch. Pharm 1994; 327: 729–734
- Quaglia F., Varrichio G., Miro A., Immacolata La Rotonda M., Larobina D., Mensitieri G. Modulation of drug release from hydrogels by using cyclodextrins: The case of nicardipine/β-cyclodextrin system in crosslinked polyethylenglycol. J. Control Release 2001; 71(3)329–337
- Ruan L. P., Yu B. Y., Fu G. M., Zhu D. N. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes. J. Pharm. Biomed. Anal 2005; 38(3)457–464
- Shimpi S., Chauhan B., Shimpi P. Cyclodextrins: application in different routes of drug administration. Acta Pharm 2005; 55(2)139–156
- Stella V. J., Rajewski R. A. Cyclodextrins: Their future in drug formulation and delivery. Pharm. Res 1997; 14(5)556–567
- Szejtli J. Cyclodextrin Technology. Informa UK Ltd, Dordrecht, Netherlands 1988
- Szente L., Szejtli J., Kis G. Spontaneous opalescence of aqueous γ-CD solutions: complex formation or self-aggregation?. J. Pharm. Sci 1998; 87(6)778–781
- Tomida H., Yotsuyanagi T., Ikeda K. Solubilization of steroid hormone by polyoxy ethylene lauryl ether. Chem. Pharm. Bull 1978; 26: 2832–2837
- Uekama K., Fujinaga F., Otagiri H., Yamasaki M. Inclusion complexations of steroid hormones with cyclodextrins in water and in solid phase. Int. J. Pharm 1982; 10(1)1–15
- Uekama K., Hirayama F., Irie T. Cyclodextrin drug carrier systems. Chem. Rev 1998; 98(5)2045–2076
- Verheyen S., Augustijns P., Kinget R., Van den Mooter G. Melting behavior of pure polyethylene glycol 6000 in solid dispersions containing diazepam or temazepam: a DSC study. Thermochim. Acta 2001; 380(2)153–164
- Wulff M., Aldén M. Solid state of drug-cyclodextrin inclusion complexes in PEG 6000 prepared by a new method. Eur. J. Pharm. Sci 1999; 8(4)269–281
- Zannou E. A., Streng W. H., Stella V. J. Osmotic properties of sulfobutylether and hydroxypropyl cyclodextrins. Pharm. Res 2001; 18(8)1226–1231